AsymBio is the core unit of the newly established strategic business segment within Asymchem Group (Stock Code: 002821.SZ/6821.HK).  AsymBio is committed to becoming a technology-driven, one-stop services CDMO company for biologics development/production that can deliver efficient, customizable and extensive high-quality services to our clients. Our all-round and personalized services offer comprehensive capabilities covering process development, product manufacturing, fill-finish, analytical development and testing, domestic and oversea regulatory registration and submission filings for a broad range of novel biopharmaceuticals including antibodies, recombinant biotherapeutics, bioconjugates, plasmids and mRNAs.